HEALTHSTREAM INC 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.   On September 13, 2023, the Company announced a share repurchase program approved by the Company’s Board under which the Company is authorized to purchase up to $10.0 million of its common stock. Pursuant to this authorization, repurchases may be made in the open market, including under a Rule 10b5-1 plan, through privately negotiated transactions, or otherwise. In addition, any repurchases under the authorization will be subject to prevailing market conditions, liquidity and cash flow considerations, applicable securities laws requirements (including under Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as applicable), and other factors. Under this program, during the three months ended September 30, 2023, the Company repurchased 99,090 shares at an aggregate fair value of 2.1 million, reflecting an average price per share of $21.60 (excluding the cost of broker commissions). The share repurchase program is scheduled to terminate on the earlier of March 31, 2024 or when the maximum dollar amount has been expended. This share repurchase program may be suspended or discontinued at any time.   The table below sets forth activity under the stock repurchase plan for the three months ended September 30, 2023.   Period   (a) Total number of shares (or units) purchased     (b) Average price paid per share (or unit)(1)     (c) Total number of shares (or units) purchased as part of publicly announced plans or programs     (d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs Month #1 (July 1 - July 31)   —   $ —     —   $ — Month #2 (August 1 - August 31)   —     —     —     — Month #3 (September 1 - September 30)   99,090     21.60     99,090     7,859,838 Total   99,090   $ 21.60     99,090   $ 7,859,838